Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$198.55 USD
-4.94 (-2.43%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $198.58 +0.03 (0.02%) 5:04 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 301 - 320 ( 387 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Operating Margins Soften but Meaningful Improvement Expected in 2H19; Raising PT
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Focus Turns to Citoxlab Deal Following 2018''s Strong Finish
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
CRL announced plans to integrate the Atomwise artificial intelligence (AI) drug discovery software into its discovery research services
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D